Related references
Note: Only part of the references are listed.IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
Hong Sun et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2022)
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
Jennifer R. Kramer et al.
HEPATOLOGY (2022)
Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease
Fu-Shun Yen et al.
FRONTIERS IN MEDICINE (2022)
Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
Lei Miao et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2022)
Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
Ashwani Sharma et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2022)
Risk associations of long-term HbA1c variability and obesity on cancer events and cancer-specific death in 15,286 patients with diabetes - A prospective cohort study
Dandan Mao et al.
LANCET REGIONAL HEALTH-WESTERN PACIFIC (2022)
Epidemiology of Hepatocellular Carcinoma
Katherine A. McGlynn et al.
HEPATOLOGY (2021)
Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway
Xin Wang et al.
CELL DEATH DISCOVERY (2021)
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
Romina Lomonaco et al.
DIABETES CARE (2021)
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis
Cori Campbell et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Association of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Clinical Outcomes
Junqing Xie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Effects of dipeptidyl peptidase-4 inhibition on portal hypertensive and cirrhotic rats
Hui-Chun Huang et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
DPP4 inhibitor reduces portal hypertension in cirrhotic rats by normalizing arterial hypocontractility
Xinxin Wang et al.
LIFE SCIENCES (2021)
High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection
Shingo Shimada et al.
HEPATOBILIARY SURGERY AND NUTRITION (2021)
Dipeptidyl Peptidase 4 Inhibitors Decrease the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Infection and Type 2 Diabetes Mellitus: A Nationwide Study in Taiwan
Wei-Hao Hsu et al.
FRONTIERS IN PUBLIC HEALTH (2021)
Effects of dipeptidyl peptidase-4 inhibition on portal hypertensive and cirrhotic rats
Hui-Chun Huang et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2021)
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
Mindie H. Nguyen et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis
Paramita Dasgupta et al.
FRONTIERS IN ONCOLOGY (2020)
Validity of ICD-10-CM Codes Used to Identify Patients with Chronic Hepatitis B and C Virus Infection in Administrative Claims Data from the Taiwan National Health Insurance Outpatient Claims Dataset
Ming-Jen Sheu et al.
CLINICAL EPIDEMIOLOGY (2020)
Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B
Terry Cheuk-Fung Yip et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Elimination of Mother-to-Infant Transmission of Hepatitis B Virus: 35 Years of Experience
Fang-Ting Lu et al.
PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION (2020)
Taiwan's Nationwide Cancer Registry System of 40 years: Past, present, and future
Chun-Ju Chiang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan
Yi-Jing Sheen et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes
Fu-Shun Yen et al.
BMC ENDOCRINE DISORDERS (2019)
Type 2 diabetes mellitus increases the risk of hepatocellular carcinoma in subjects with chronic hepatitis B virus infection: a meta-analysis and systematic review
Yifei Tan et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice
Sohji Nishina et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus
Ning Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Mother-to-infant transmission of hepatitis B virus: challenges and perspectives
Yi-Fen Shih et al.
HEPATOLOGY INTERNATIONAL (2017)
Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitus
Yoshio Sumida et al.
HEPATOLOGY RESEARCH (2017)
Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients
Jung Hee Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
The prescribing trend of oral antidiabetic agents for type 2 diabetes in Taiwan: An 8-year population-based study
Wei-Min Chu et al.
MEDICINE (2017)
Eradicating hepatitis B virus: The critical role of preventing perinatal transmission
Cladd E. Stevens et al.
BIOLOGICALS (2017)
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
Alessandro Mantovani et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Increased Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients With Newly Diagnosed Diabetes: A Nationwide Cohort Study
Yi-Wen Huang et al.
CLINICAL INFECTIOUS DISEASES (2013)
Diabetes, hepatitis virus infection and hepatocellular carcinoma: A case-control study in hepatitis endemic area
Wei-Hsu Ko et al.
HEPATOLOGY RESEARCH (2012)
Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance: A Community-Based Follow-up Study
Jessica Liu et al.
GASTROENTEROLOGY (2010)